Manulife (Manufacturers Life Insurance)’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $212K | Sell |
22,575
-353
| -2% | -$3.32K | ﹤0.01% | 2531 |
|
2025
Q1 | $124K | Sell |
22,928
-48,310
| -68% | -$262K | ﹤0.01% | 2645 |
|
2024
Q4 | $531K | Buy |
71,238
+3,657
| +5% | +$27.2K | ﹤0.01% | 2208 |
|
2024
Q3 | $540K | Sell |
67,581
-462
| -0.7% | -$3.69K | ﹤0.01% | 2258 |
|
2024
Q2 | $592K | Sell |
68,043
-8,496
| -11% | -$73.9K | ﹤0.01% | 2140 |
|
2024
Q1 | $1.58M | Buy |
76,539
+2,118
| +3% | +$43.8K | ﹤0.01% | 1606 |
|
2023
Q4 | $1.72M | Buy |
74,421
+21,482
| +41% | +$496K | ﹤0.01% | 1523 |
|
2023
Q3 | $423K | Buy |
+52,939
| New | +$423K | ﹤0.01% | 2209 |
|
2022
Q4 | – | Sell |
-11,216
| Closed | -$88.7K | – | 2971 |
|
2022
Q3 | $88.7K | Sell |
11,216
-478
| -4% | -$3.78K | ﹤0.01% | 2841 |
|
2022
Q2 | $92K | Buy |
+11,694
| New | +$92K | ﹤0.01% | 2932 |
|
2022
Q1 | – | Sell |
-11,490
| Closed | -$141 | – | 3105 |
|
2021
Q4 | $141 | Buy |
11,490
+834
| +8% | +$10 | ﹤0.01% | 2998 |
|
2021
Q3 | $111K | Buy |
+10,656
| New | +$111K | ﹤0.01% | 3094 |
|
2020
Q2 | – | Sell |
-4,272
| Closed | -$44K | – | 2871 |
|
2020
Q1 | $44K | Buy |
4,272
+1,174
| +38% | +$12.1K | ﹤0.01% | 2751 |
|
2019
Q4 | $48K | Buy |
3,098
+1,177
| +61% | +$18.2K | ﹤0.01% | 2851 |
|
2019
Q3 | $35K | Buy |
+1,921
| New | +$35K | ﹤0.01% | 2881 |
|